Filing Details

Accession Number:
0001209191-14-078282
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-12-29 21:40:15
Reporting Period:
2014-12-23
Filing Date:
2014-12-29
Accepted Time:
2014-12-29 21:40:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1114220 Keryx Biopharmaceuticals Inc KERX Pharmaceutical Preparations (2834) 134087132
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1251213 Ron Bentsur C/O Keryx Biopharmaceuticals, Inc.
750 Lexington Avenue
New York NY 10022
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-12-23 104,489 $13.98 1,151,488 No 4 S Direct
Common Stock Disposition 2014-12-24 83,000 $13.98 1,068,488 No 4 S Direct
Common Stock Disposition 2014-12-26 63,500 $13.98 1,004,988 No 4 S Direct
Common Stock Disposition 2014-12-29 87,988 $13.98 917,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Sales of a total of 338,977 shares of common stock were made between December 23, 2014 and December 29, 2014, at an average sale price of $13.98 per share, in order to satisfy Mr. Bentsur's income tax withholding obligation upon the vesting of 766,666 shares of restricted stock on December 22, 2014, pursuant to the terms of his employment agreement and the achievement of a corporate milestone. Mr. Bentsur had no discretion with respect to such sales, which were transacted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock.
  2. Includes 39,775 shares of restricted stock.